Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phospholipid signaling pathway is a fundamental cellular mechanism in which membrane phospholipids act as precursors for the generation of lipid-derived second messengers. These messengers transmit signals from activated cell surface receptors to intracellular targets, orchestrating diverse physiological responses such as cell proliferation, differentiation, migration, and survival. Key components include phospholipids (PIP2, PC), enzymes (PLC, PLD, PLA2), and second messengers (DAG, IP3). Upon ligand binding to receptors, PLC activation cleaves PIP2 into DAG and IP3. IP3 triggers Ca²⁺ release, and elevated Ca²⁺ with DAG activates PKC family enzymes, which phosphorylate downstream targets. Other branches involve PLD generating PA or PLA2 producing modulatory lipids. It regulates cell growth, differentiation, apoptosis, vesicular trafficking, and immune responses. Dysregulation is implicated in cancer, neurological disorders, and metabolic diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipid Signaling Pathway.